Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B K Skrumsager

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Obesity|January 1, 1987
Femoxetine in the treatment of obese patients in general practice. A randomized group comparative study with placeboM Bitsch, B K Skrumsager
Pharmacopsychiatry|September 1, 1986
Femoxetine and amitriptyline in general practice: a randomized double-blind group comparisonB K Skrumsager, K Jeppesen
British Journal of Clinical Pharmacology|March 1, 1989
Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy menS J Warrington, P Turner, B K Skrumsager
Clinical Therapeutics|February 24, 2001
Pharmacokinetics of levormeloxifene in young versus elderly postmenopausal womenB Kiehr, B K Skrumsager, M Müller, et al.
Psychopharmacology|October 1, 1995
Tolerability, safety and pharmacokinetics of single dose and multiple dosing of the selective D1 antagonist NNC 01-0687 in healthy subjectsB K Skrumsager, J V Christensen, S Snel, et al.
Journal of Clinical Pharmacology|October 11, 2003
Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetesB K Skrumsager, K K Nielsen, M Müller, et al.
International Clinical Psychopharmacology|October 1, 1990
A tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR 12909 in healthy subjectsU Søgaard, J Michalow, B Butler, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Obesity|January 1, 1987
Femoxetine in the treatment of obese patients in general practice. A randomized group comparative study with placeboM Bitsch, B K Skrumsager
Pharmacopsychiatry|September 1, 1986
Femoxetine and amitriptyline in general practice: a randomized double-blind group comparisonB K Skrumsager, K Jeppesen
British Journal of Clinical Pharmacology|March 1, 1989
Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy menS J Warrington, P Turner, B K Skrumsager
Clinical Therapeutics|February 24, 2001
Pharmacokinetics of levormeloxifene in young versus elderly postmenopausal womenB Kiehr, B K Skrumsager, M Müller, et al.
Psychopharmacology|October 1, 1995
Tolerability, safety and pharmacokinetics of single dose and multiple dosing of the selective D1 antagonist NNC 01-0687 in healthy subjectsB K Skrumsager, J V Christensen, S Snel, et al.
Journal of Clinical Pharmacology|October 11, 2003
Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetesB K Skrumsager, K K Nielsen, M Müller, et al.
International Clinical Psychopharmacology|October 1, 1990
A tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR 12909 in healthy subjectsU Søgaard, J Michalow, B Butler, et al.
Pageof 1